Elevating Cell and Gene Therapy Logistics: 7 ways CSafe adds value outside the box
You probably know CSafe for our industry-leading thermal shipping solutions. But you might be surprised to learn that our service...
Read more
Rethinking logistics, the key barrier to scaling cell and gene therapies
For cell and gene therapies to scale, they need simple, flexible supply chains. Personalized cell and gene therapies offer a...
Read moreCell and Gene Therapy in 2023 – It’s All About Access
This year, thousands of cell and gene therapy clinical trials are running around the world. Some of those studies have...
Read more
Cell & Gene Therapy Logistics Planning and Scaleup
The vibrant and growing pipeline of cell and gene therapies (CGT) provides many exciting clinical opportunities for patients and their...
Read more
Cell & Gene Therapy Commercialization Logistics: 3 Critical Questions to Ask when Choosing a Thermal Shipping Container
Among today’s temperature-sensitive pharmaceutical products requiring specialized handling, transport and storage, cell and gene therapies (CGT) need even more precise...
Read more
Cell and gene therapies: Managing COVID-19 disruptions, both upstream and downstream
The time-sensitive, temperature-sensitive supply chain for cell-and-gene therapies (CGT) requires a highly coordinated, highly choreographed dance under the best of...
Read more
Achieving Irrefutable Chain of Custody for Cell & Gene Therapies with Smart Technologies
Chain of custody (COC) in the simplest of terms, details the location and time an item changed hands and who...
Read more
The True Cost of a Cell & Gene Payload
As the cell and gene industry continues to grow manufacturers must determine where it is – and is not –...
Read more
Safeguarding the Cell & Gene Supply Chain – Building Flexibility
Emilio Frattaruolo, CPP, Vice President of Innovation, Passive Systems discusses how to build flexibility into the cell and gene therapy...
Read more
Safeguarding the Cell & Gene Supply Chain – Part 2
Emilio Frattaruolo, CPP, Vice President of Innovation, Passive Systems discusses how to mitigate risk in the cell and gene therapy...
Read more
Safeguarding the Cell & Gene Supply Chain – Part 1
Emilio Frattaruolo, CPP, Vice President of Innovation, Passive Systems discusses how to manage compliance in the cell and gene therapy...
Read more